Option Care Health, Inc. (NASDAQ:OPCH) Given Average Rating of “Moderate Buy” by Brokerages

Option Care Health, Inc. (NASDAQ:OPCH) has been assigned a consensus rating of “Moderate Buy” from the fourteen research firms that are currently covering the stock, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $29.9231.

OPCH has been the topic of a number of recent analyst reports. Barrington Research dropped their price objective on Option Care Health from $42.00 to $32.00 and set an “outperform” rating on the stock in a research note on Friday, May 1st. UBS Group reaffirmed a “buy” rating on shares of Option Care Health in a research note on Tuesday, June 16th. Stephens reiterated an “equal weight” rating and issued a $24.00 target price (down from $30.00) on shares of Option Care Health in a report on Friday, July 17th. TD Cowen dropped their price target on Option Care Health from $37.00 to $23.00 and set a “hold” rating on the stock in a research note on Friday, May 1st. Finally, Wall Street Zen upgraded Option Care Health from a “hold” rating to a “buy” rating in a report on Saturday, August 1st.

Option Care Health Stock Up 0.6%

Shares of NASDAQ OPCH opened at $23.49 on Friday. The company’s 50 day moving average price is $22.30 and its 200-day moving average price is $25.60. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.98 and a current ratio of 1.47. Option Care Health has a 52-week low of $18.01 and a 52-week high of $36.80. The company has a market capitalization of $3.52 billion, a P/E ratio of 17.66, a price-to-earnings-growth ratio of 1.35 and a beta of 0.65.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. The company had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.42 billion. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. Option Care Health’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same period in the prior year, the company posted $0.41 earnings per share. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. Equities analysts forecast that Option Care Health will post 1.69 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of OPCH. McIlrath & Eck LLC bought a new stake in Option Care Health in the second quarter valued at $37,000. Advisory Services Network LLC bought a new position in shares of Option Care Health during the 3rd quarter worth about $35,000. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Option Care Health in the 3rd quarter valued at about $38,000. Employees Retirement System of Texas acquired a new stake in shares of Option Care Health in the 4th quarter valued at about $45,000. Finally, EverSource Wealth Advisors LLC increased its position in Option Care Health by 528.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock valued at $46,000 after buying an additional 1,183 shares in the last quarter. 98.05% of the stock is owned by institutional investors.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.